新兴的Bach1小分子抑制剂作为治疗剂:理由,最近的进展和未来的前景
Dmitry M Hushpulian1,2, Navneet Ammal Kaidery3,4, Debashis Dutta3,4
1Faculty of Biology and Biotechnologies, Higher School of Economics, Moscow, Russia.
概括
转录因子 Nrf2 调节细胞压力. 抑制抑制Nrf2的Bach1,与Nrf2激活一起,为帕金森氏症等疾病提供了一个有希望的神经治疗策略.
科学领域:
- 生物化学 生物化学
- 神经科学是一个神经科学.
- 分子生物学分子生物学
背景情况:
- 核因子红色素2相关因子2 (Nrf2) 是细胞防御机制的关键调节者.
- 目前的Nrf2激活剂由于非特异性化活性和副作用而存在限制.
- 巴赫1,一个转录抑制剂和血红质传感器,负面调节Nrf2活动.
研究的目的:
- 探索针对Bach1/Nrf2信号通路的治疗潜力.
- 审查开发小分子Bach1抑制剂的进展.
- 为了强调这种途径在神经退行性疾病中的重要性.
主要方法:
- 对Nrf2和Bach1函数的文献综述.
- 分析巴赫1在神经退行性疾病发病过程中的作用.
- 对巴赫的小分子抑制剂开发的讨论1.
主要成果:
- 在神经退行性疾病中,Bach1积累会干扰Nrf2激活.
- 在血结合后的Bach1降解缓解了Nrf2抑制.
- 结合Nrf2稳定和Bach1抑制可以提高治疗结果.
结论:
- 巴赫1/Nrf2通路是一个有前途的神经治疗点.
- 开发特定的Bach1抑制剂对于最大限度地发挥Nrf2的益处至关重要.
- 针对这种途径提供了一个新的神经保护策略.
相关概念视频
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
01:31The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K